Axsome Therapeutics, Inc.
Clinical trials sponsored by Axsome Therapeutics, Inc., explained in plain language.
-
New hope for depressed patients who struggle to stay awake
Disease control Recruiting nowThis study is testing whether a drug called solriamfetol can help control symptoms in adults with major depression who also experience severe daytime sleepiness. First, all 508 participants will receive the active drug. Those who respond well will then be randomly assigned to eit…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for controlling binge eating episodes
Disease control Recruiting nowThis study is testing whether a medication called solriamfetol can help reduce binge eating episodes in adults with binge eating disorder. About 450 participants will take either the medication at one of two doses or a placebo pill daily for 12 weeks. The main goal is to see if t…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New fibromyalgia drug shows promise in major trial
Disease control Recruiting nowThis study is testing whether the medication AXS-14 can help control fibromyalgia symptoms. The trial will involve 620 adults diagnosed with fibromyalgia who will first receive the drug for 12 weeks. Those who respond well will then be randomly assigned to either continue the med…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
New hope for night shift workers battling extreme sleepiness
Symptom relief Recruiting nowThis study is testing whether a medication called solriamfetol can help adults who work night shifts and struggle with severe sleepiness. About 520 participants will take either the drug or a placebo for 12 weeks to see if it improves their ability to stay awake and alert during …
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC